Curvebeam AI Ltd. (AU:CVB) has released an update.
CurveBeam AI Ltd. has successfully issued 11,111,111 new shares at $0.18 each to KP Rx Healthcare Opportunities Fund as part of its second tranche of institutional placement. This move is a strategic effort to bolster its capital, supporting the company’s ongoing development of cutting-edge medical imaging technology. The newly issued shares will have the same rights as existing shares, signaling a promising step for investors interested in the company’s growth trajectory.
For further insights into AU:CVB stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
